Intravenous iron treatment in the puerperium

Danish Medical Journal

Volumn 65, Issue 4, 2018, Pages

  Holm, Charlotte ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON; BIOLOGICAL MARKER;

ADULT; ANEMIA; ARTICLE; BLEEDING; BREAST MILK; ERYTHROPOIESIS; FEMALE; HUMAN; IRON DEFICIENCY; MALE; POSTPARTUM HEMORRHAGE; PUERPERIUM; BLOOD; COMPLICATION; DENMARK; DEPRESSION; DOSE RESPONSE; ERYTHROCYTE TRANSFUSION; FATIGUE; FEASIBILITY STUDY; INTRAVENOUS DRUG ADMINISTRATION; IRON DEFICIENCY ANEMIA; PATIENT-REPORTED OUTCOME; PILOT STUDY; PREGNANCY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SEVERITY OF ILLNESS INDEX;

ANEMIA, IRON-DEFICIENCY; BIOMARKERS; DENMARK; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTE TRANSFUSION; FATIGUE; FEASIBILITY STUDIES; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; IRON; PATIENT REPORTED OUTCOME MEASURES; PILOT PROJECTS; POSTPARTUM HEMORRHAGE; POSTPARTUM PERIOD; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 85044957415     PISSN: None     EISSN: 22451919     Source Type: Journal    
DOI: None     Document Type: Article

References (105)

1. de Benoist B, McLean E, Egli I, Cogswell M. Worldwide prevalence of anaemia 1993-2005: WHO global database on anaemia. Geneva: World Health Organization; 2008.
2. Lopez A, Cacoub P, Macdougall IC, Peyrin-Biroulet L. Iron deficiency anaemia. Lancet. 2015 Aug 24: doi: 10.1016/S0140-6736(15)60865-0. [Epub ahead of print]
3. Knight M, Callaghan WM, Berg C, Alexander S, Bouvier-Colle M-H, Ford JB, et al. Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Pregnancy and Childbirth. 2009;9(1):55. doi: 10.1186/1471-2393-9-55.
4. Milman N. Postpartum anemia I: definition, prevalence, causes, and consequences. Ann Hematol. 2011;90(11):1247–53.
5. Jansen AJ, van Rhenen DJ, Steegers EA, Duvekot JJ. Postpartum hemorrhage and transfusion of blood and blood components. Obstet Gynecol Surv. 2005;60(10):663–71.
6. Bodnar LM, Cogswell ME, McDonald T. Have we forgotten the significance of postpartum iron deficiency? American Journal of Obstetrics and Gynecology. 2005;193(1):36–44.
7. Richter C, Huch A, Huch R. Erythropoiesis in the postpartum period. Journal of Perinatal Medicine. 1995;23(1-2):51–9.
8. Besarab A, Horl WH, Silverberg D. Iron metabolism, iron deficiency, thrombocytosis, and the cardiorenal anemia syndrome. Oncologist. 2009;14(Supplement 1):22–33.
9. Mast AE, Blinder MA, Dietzen DJ. Reticulocyte hemoglobin content. Am J Hematol. 2008;83(4):307–10.
10. Muñoz M, Villar I, García-Erce JA. An update on iron physiology. World J Gastroenterol. 2009;15(37):4617–26.
11. Andrews NC. Forging a field: the golden age of iron biology. Blood. 2008;112(2):219–30.
12. Andrews NC. Iron homeostasis: insights from genetics and animal models. Nat Rev Genet. 2000;1(3):208–17.
13. Andrews NC. Disorders of iron metabolism. N Engl J Med. 1999;341(26):1986–95.
14. Hasudungan A. Iron Physiology [Internet]. Youtube; 2014[cited 2015 Nov 5]. Available from Youtube: https://www.youtube.com/watch?v=ahCy97FVU pM
15. Steinbicker A, Muckenthaler M. Out of Balance— Systemic iron homeostasis in iron-related disorders. Nutrients. 2013;5(8):3034–61.
16. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306(5704):2090–3.
17. Pavord S, Myers B, Robinson S, Allard S, Strong J, Oppenheimer C, et al. UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol. 2012;156(5):588–600.
18. Hallberg L, Bengtsson C, Lapidus L, Lindstedt G, Lundberg PA, Hultén L. Screening for iron deficiency: an analysis based on bone-marrow examinations and serum ferritin determinations in apopulation sample of women. Br J Haematol. 1993;85(4):787–98.
19. Munoz M, Garcia-Erce JA, Remacha AF. Disorders of iron metabolism. Part II: iron deficiency and iron overload. Journal of Clinical Pathology. 2011;64(4):287–96.
20. Milman N, Agger AO, Nielsen OJ. Iron supplementation during pregnancy. Effect on iron status markers, serum erythropoietin and human placental lactogen. A placebo controlled study in 207 Danish women. Dan Med Bull. 1991;38(6):471–6.
21. Huch R, Breymann C. Anaemia in pregnancy and the puerperium. Bremen: UNI-MED Verlag AG, International Medical Publishers; 2005.
22. World Health Organisation. WHO Guidelines for the Management of postpartum haemorrhage and retained Placenta. Geneva: WHO; 2009.
23. Koury MJ, Ponka P. New insights into erythropoiesis: The roles of folate, vitamin B 12, and iron. Annu Rev Nutr. 2004;24(1):105–31.
24. Cunningham FG, Williams JW. Williams Obstetrics. 23rd ed. New York: McGraw-Hill Medical; 2010.
25. McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993–2005. Public Health Nutr. 2009;12(4):444–54.
26. Al-Zirqi I, Vangen S, Forsen L, Stray-Pedersen B. Prevalence and risk factors of severe obstetric haemorrhage. BJOG. 2008;115(10):1265–72.
27. Bergmann RL, Richter R, Bergmann KE, Duden-hausen JW. Prevalence and risk factors for early postpartum anemia. Eur J Obstet Gynecol Reprod Biol. 2010;150(2):126–31.
28. Milman N, Clausen J, Byg KE. Iron status in 268 Danish women aged 18-30 years: influence of menstruation, contraceptive method, and iron supplementation. Ann Hematol. 1998;77(1-2):13–9.
29. Lee KA, Zaffke ME. Longitudinal changes in fatigue and energy during pregnancy and the postpartum period. J Obstet Gynecol Neonatal Nurs. 1999;28(2):183–91.
30. Rioux FM, Savoie N, Allard J. Is there a link between postpartum anemia and discontinuation of breastfeeding? Can J Diet Pract Res. 2006;67(2):72–6.
31. Scott SP, Murray-Kolb LE. Iron status is associated with performance on executive functioning tasks in nonanemic young women. J Nutr. 2016;146(1):30-7.
32. Holm C, Langhoff-Roos J, Petersen KB, Norgaard A, Diness BR. Severe postpartum haemorrhage and mode of delivery: a retrospective cohort study. BJOG. 2012;119(5):596–604.
33. Sundhedsstyrelsen. National klinisk retningslinje om indikation for transfusion med blodkompo-nenter [Internet]. Copenhagen: Sundhedsstyrelsen; 2014[cited 2015 Nov 5]. Available from Sundhedsstyrelsen: https://sundhedsstyrelsen.dk/da/udgivelser/201 4/~/media/EEA1EA90C15E4A97B9E786D2850B3 664.ashx
34. Silverman JA, Barrett J, Callum JL. The appropriateness of red blood cell transfusions in the peri-partum patient. Obstet Gynecol. 2004;104(5, Part 1):1000–4.
35. Carson JL, Carless PA, Hebert PC. Transfusion thresholds and other strategies for guiding al-logeneic red blood cell transfusion. Cochrane Database of Systematic Reviews 2012, Issue 4. Art. No.: CD002042. doi:10.1002/14651858.CD002042.pub3.
36. Lee T-H, Paglieroni T, Utter GH, Chafets D, Gosselin RC, Reed W, et al. High-level long-term white blood cell microchimerism after transfusion of leukoreduced blood components to patients resuscitated after severe traumatic injury. Transfusion. 2005;45(8):1280–90.
37. Salpeter SR, Buckley JS, Chatterjee S. Impact of more restrictive blood transfusion strategies on clinical outcomes: a meta-analysis and systematic review. Am J Med. 2014;127(2):124–131.e3.
38. Norgaard A, Gybel-Brask M, Rieneck K, Christensen BK, El-Ghina RZ, Johansson PI, et al. Managing the bleeding emergency in a patient with red cell antibodies. ISBT science series. 2015 Oct;(In press).
39. Milman N, Bergholt T, Eriksen L, Byg K-E, Graudal N, Pedersen P, et al. Iron prophylaxis during pregnancy -- how much iron is needed? A randomized dose- response study of 20-80 mg ferrous iron daily in pregnant women. Acta Obstet Gynecol Scand. 2005;84(3):238–47.
40. Markova V, Norgaard A, Jørgensen KJ, Langhoff-Roos J. Treatment for women with postpartum iron deficiency anaemia. Cochrane Database of Systematic Reviews 2015, Issue 8. Art. No.: CD010861. doi: 10.1002/14651858.CD010861.pub2.
41. Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015;372(19):1832–43.
42. Geisser P, Baer M, Schaub E. Struc-ture/histotoxicity relationship of parenteral iron preparations. Arzneimittelforschung. 1992;42(12):1439–52.
43. Lyseng-Williamson KA, Keating GM. Ferric carboxymaltose: a review of its use in iron-deficiency anaemia. Drugs. 2009;69(6):739–56.
44. Jahn MR, Andreasen HB, Fütterer S, Nawroth T, Schünemann V, Kolb U, et al. A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implications. Eur J Pharm Biopharm. 2011;78(3):480–91.
45. Wikström B, Bhandari S, Barany P, Kalra PA, Ladefoged S, Wilske J, et al. Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease. J Nephrol. 2011;24(5):589–96.
46. Reinisch W, Staun M, Tandon RK, Altorjay I, Thil-lainayagam AV, Gratzer C, et al. A randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED). Am J Gastroenterol. 2013;108(12):1877–88.
47. Bhandari S, Kalra PA, Kothari J, Ambühl PM, Christensen JH, Essaian AM, et al. A randomized, open-label trial of iron isomaltoside 1000 (Mon-ofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients. Nephrol Dial Transplant. 2015;30(9):1577–89.
48. Johansson PI, Rasmussen AS, Thomsen LL. Intravenous iron isomaltoside 1000 (Monofer®) reduces postoperative anaemia in preoperatively non-anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: a randomized double-blind placebo-controlled clinical trial (the PROTECT trial). Vox Sang. 2015;109(3):257– 66.
49. Reinisch W, Altorjay I, Zsigmond F, Primas C, Vogelsang H, Novacek G, et al. A 1-year trial of repeated high-dose intravenous iron isomaltoside 1000 to maintain stable hemoglobin levels in inflammatory bowel disease. Scand J Gastroenterol. 2015;50(10):1226–33.
50. Kalra PA, Bhandari S, Saxena S, Agarwal D, Wirtz G, Kletzmayr J, et al. A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia. Nephrol Dial Transplant. 2015; pii:gfv293. [Epub ahead of print]
51. Merino SG, Picado AL, Hernández HM, Mesa JM, Lasa IL, Barandiarán FA.Ensayo clínico aleatoriza-do para evaluar la efectividad de dos vías de ad-ministración de hierro, oral e intravenosa, en el tratamiento de la anemia ferropénica posparto. Clínica Investigación Ginecol Obstetricia. 2012;39:190–5 [in Spanish].
52. Westad S, Backe B, Salvesen KÅ, Nakling J, Økland I, Borthen I, et al. A 12-week randomised study comparing intravenous iron sucrose versus oral ferrous sulphate for treatment of postpartum anemia. Acta Obstet Gynecol Scand. 2008;87(9):916–23.
53. Bhandal N, Russell R. Intravenous versus oral iron therapy for postpartum anaemia. BJOG. 2006;113(11):1248–52.
54. Van Wyck DB, Martens MG, Seid MH, Baker JB, Mangione A. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial. Obstet Gynecol. 2007;110(2 Pt 1):267–78.
55. Seid MH, Derman RJ, Baker JB, Banach W, Goldberg C, Rogers R. Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial. Am J Obstet Gynecol. 2008;199(4):435.e1-7.
56. Breymann C, Gliga F, Bejenariu C, Strizhova N. Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia. Int J Gynaecol Obstet. 2008;101(1):67–73.
57. Verma S, Inamdar SA, Malhotra N. Intravenous iron therapy versus oral iron in postpartum patients in rural area. J SAFOG. 2011;3(2):67–70.
58. Froessler B, Cocchiaro C, Saadat-Gilani K, Hodyl N, Dekker G. Intravenous iron sucrose versus oral iron ferrous sulfate for antenatal and postpartum iron deficiency anemia: a randomized trial. J Matern Fetal Neonatal Med. 2013;26(7):654–9.
59. Jain G, Palaria U, Jha SK. Intravenous iron in postpartum anemia. J Obstet Gynecol India. 2013;63(1):45–8.
60. Mumtaz A, Farooq F. Comparison for effects of intravenous versus oral iron therapy for postpartum anemia. Pakistan Journal of Medical and Health Sciences. 2011;5(1):116–20.
61. Prick BW, Jansen A, Steegers E, Hop W, Essink-Bot ML, Uyl-de Groot CA, et al. Transfusion policy after severe postpartum haemorrhage: a randomised non-inferiority trial. BJOG. 2014;121(8):1005–14.
62. Broche DE, Gay C, Armand-Branger S, Grangeasse L, Terzibachian JJ. Anémies sévères du postpartum immédiat. Pratique clinique et intérêt du fer par voie intraveineuse. Gynécologie Obstétri-que & Fertilité. 2004;32(7-8):613–9.
63. Fayers PM, Machin D. Quality of Life. 2nd edition. Chichester, UK: John Wiley & Sons, Ltd; 2007.
64. Sobrero A, Puglisi F, Guglielmi A, Belvedere O, Aprile G, Ramello M, et al. Fatigue: a main component of anemia symptomatology. Semin Oncol. 2001;28(2 Suppl 8):15–8.
65. Bager P. Fatigue and acute/chronic anaemia. Dan Med J. 2014;61(4):B4824.
66. Smets EM, Garssen B, Bonke B, De Haes JC. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39(3):315–25.
67. Jansen AJ, Essink-Bot M-L, Duvekot JJ, van Rhenen DJ. Psychometric evaluation of health-related quality of life measures in women after different types of delivery. J Psychosom Res. 2007;63(3):275–81.
68. Corwin EJ, Murray-Kolb LE, Beard JL. Low hemoglobin level is a risk factor for postpartum depression. J Nutr. 2003;133(12):4139–42.
69. Albacar G, Sans T, Martín-Santos R, García-Esteve L, Guillamat R, Sanjuan J, et al. An association between plasma ferritin concentrations measured 48h after delivery and postpartum depression. J Affect Disord. 2011;131(1-3):136–42.
70. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry. 1987;150(6):782–6.
71. Gibson J, McKenzie-McHarg K, Shakespeare J, Price J, Gray R. A systematic review of studies validating the Edinburgh Postnatal Depression Scale in antepartum and postpartum women. Acta Psychiatr Scand. 2009;119(5):350–64.
72. Nakamori M, Ninh NX, Isomura H, Yoshiike N, Hien VTT, Nhug BT, et al. Nutritional status of lactating mothers and their breast milk concentration of iron, zinc and copper in rural Vietnam. J Nutr Sci Vitaminol. 2009;55(4):338–45.
73. Yalcin SS, Baykan A, Yurdakök K, Yalcin S, Gücüs AI. The factors that affect milk-to-serum ratio for iron during early lactation. J Pediatr Hematol Oncol. 2009;31:85-90.
74. Lönnerdal B. Effects of maternal dietary intake ohuman milk composition. J Nutr. 1986;116(4):499–513.
75. Zavaleta N, Nombera J, Rojas R, Hambraeus L, Gislason J, Lönnerdal B. Iron and lactoferrin in milk of anemic mothers given iron supplements. Nutrition Research. 1995;15(5):1681–90.
76. Kumar A, Rai AK, Basu S, Dash D, Singh JS. Cord blood and breast milk iron status in maternal anemia. Pediatrics. 2008;121(3):e673–7.
77. França EL, Silva VA, Volpato RMJ, Silva PA, Brune MFSS, Honorio-França AC. Maternal anemia in- duces changes in immunological and nutritional components of breast milk. J Matern Fetal Neonatal Med. 2013;26(12):1223–7.
78. Quinn EA. Too much of a good thing: evolutionary perspectives on infant formula fortification in the United States and its effects on infant health. Am J Hum Biol. 2014;26(1):10–7.
79. Breymann C, Seefried von B, Stahel M, Geisser P, Canclini C. Milk iron content in breast-feeding mothers after administration of intravenous iron sucrose complex. J Perinat Med. 2007;35(2):115-8.
80. Breymann C, Gliga F, Bejenariu C, Strizhova N. Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia. Int J Gynaecol Obstet. 2008;101(1):67–73.
81. American Academy of Pediatrics, Committee on Nutrition. Iron fortification of infant formulas. Pediatrics. 1999;104:119-23.?
82. Bullen JJ, Ward CG, Rogers HJ. The critical role of iron in some clinical infections. Eur J Clin Microbiol Infect Dis. 1991;10(8):613–7.
83. Domellöf M. Iron requirements, absorption and metabolism in infancy and childhood. Curr Opin Clin Nutr Metab Care. 2007;10(3):329–35.
84. Moy RJ. Iron fortification of infant formula. Nutr Res Rev. 2000;13(2):215–27.
85. The Danish National Committee on Health Research Ethics [Internet]. [cited 2015 Nov 5]. Available from: http://www.cvk.sum.dk/CVK/Home/English.aspx.
86. The Danish Medicines Agency [Internet]. [cited 2015 Nov 5]. Available from: https://sundhedsstyrelsen.dk/en/medicines/regu lation/clinical-trials.
87. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline - Guideline for Good Clinical Practice E6 (R1). London: European Medicines Agency; 2002.
88. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol. 2010;63(8):e1-37.
89. Turawa EB, Musekiwa A, Rohwer AC. Interventions for preventing postpartum constipation. Cochrane Database of Systematic Reviews 2015, Issue 9. Art. No.: CD011625. DOI: 10.1002/14651858.CD011625.pub2.
90. Carson JL, Grossman BJ, Kleinman S, Tinmouth AT, Marques MB, Fung MK, et al. Red blood cell transfusion: a clinical practice guideline from the AABB*. Ann Intern Med. 2012;157(1):49-58.91. 1
91. Jansen AJ, Duvekot JJ, Hop WC, Essink-Bot M-L, Beckers EA, Karsdorp VH, et al. New insights into fatigue and health-related quality of life after delivery. Acta Obstet Gynecol Scand. 2007;86(5):579–84. 1
92. Freeman LM, Bloemenkamp KW, Franssen MT, Papatsonis DN, Hajenius PJ, Hollmann MW, et al. Patient controlled analgesia with remifentanil versus epidural analgesia in labour: randomised multicentre equivalence trial. BMJ. 2015;350:h846. 1
93. Cappelleri JC, Bushmakin AG, Zlateva G, Sadosky A. Pain responder analysis: Use of area under the curve to enhance interpretation of clinical trial results. Pain Practice. 2009;9(5):348–53.
94. Schroll JB, Maund E, Gøtzsche PC. Challenges in coding adverse events in clinical trials: A systematic review. PLoS ONE. 2012;7(7):e41174.
95. European Medicines Agency. Assessments Report for: Iron containing intravenous (IV) medicinal products. London: European Medicines Agen-cy;2013.
96. Fishbane S, Ungureanu VD, Maesaka JK, Kaupke CJ, Lim V, Wish J. The safety of intravenous iron dextran in hemodialysis patients. Am J Kidney Dis. 1996;28(4):529–34.
97. Auerbach M, Ballard H, Glaspy J. Clinical update: intravenous iron for anaemia. Lancet. 2007;369(9572):1502–4.
98. Rampton D, Folkersen J, Fishbane S, Hedenus M, Howaldt S, Locatelli F, et al. Hypersensitivity reactions to intravenous iron: guidance for risk mini-mization and management. Haematologica. 2014;99(11):1671–6.
99. Domellöf M, Lönnerdal B, Dewey KG, Cohen RJ, Hernell O. Iron, zinc, and copper concentrations in breast milk are independent of maternal mineral status. Am J Clin Nutr. 2004;79(1):111–5.
100. Dorea JG. Iron and copper in human milk. Nutrition. 2000;16(3):209–20.
101. Feeley RM, Eitenmiller RR, Jones JB, Barnhart H. Copper, iron, and zinc contents of human milk at early stages of lactation. Am J Clin Nutr. 1983;37(3):443–8.
102. Siimes MA, Vuori E, Kuitunen P. Breast milk iron--a declining concentration during the course of lactation. Acta Paediatr Scand. 1979;68(1):29–31.
103. Fransson GB, Lönnerdal B. Iron in human milk. J Pediatr. 1980;96(3 Pt 1):380–4.
104. Koletzko B, Baker S, Cleghorn G, Neto UF, Go-palan S, Hernell O, et al. Global standard for the composition of infant formula: recommendations of an ESPGHAN coordinated international expert group. J Pediatr Gastroenterol Nutr. 2005;41(5):584–99.
105. Baker RD, Greer FR, Committee on Nutrition American Academy of Pediatrics. Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0-3 years of age). Pediatrics. 2010;126(5):1040–50.